Matinas Biopharma Hl (MTNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Operating Expenses | 1,804 | 1,453 | 343 | 112 | 0 |
| Operating Income | -1,804 | -1,453 | -343 | -112 | N/A |
| Other Income | -4 | 3 | 0 | 0 | 0 |
| Pre-tax Income | -1,808 | -1,450 | -343 | -112 | 0 |
| Net Income Continuous | -1,808 | -1,450 | -343 | -112 | N/A |
| Net Income | $-1,808 | $-1,450 | $-343 | $-112 | $N/A |
| EPS Basic Total Ops | -3.00 | -5.00 | -1.50 | -0.50 | N/A |
| EPS Basic Continuous Ops | -2.63 | -4.87 | -1.72 | -0.56 | N/A |
| EPS Diluted Total Ops | -3.00 | -5.00 | -1.50 | -0.50 | N/A |
| EPS Diluted Continuous Ops | -2.63 | -4.87 | -1.72 | -0.56 | N/A |
| EBITDA(a) | $-1,803 | $-1,456 | $-343 | $-112 | $N/A |